Human Molecular Genetics

Papers
(The H4-Index of Human Molecular Genetics is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Human Molecular Genetics Review Issue 202279
A molecular map of long non-coding RNA expression, isoform switching and alternative splicing in osteoarthritis66
Clonal hematopoiesis as a pitfall in germline variant interpretation in the context of Mendelian disorders55
The rs6576457 G > A variant in the MKRN3 gene promoter significantly increases the risk of central precocious puberty and lung cancer in Hubei Chinese population52
A pathogenic DYT-THAP1 dystonia mutation causes hypomyelination and loss of YY1 binding48
Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation ofOBFC148
Long term peripheral AAV9-SMN gene therapy promotes survival in a mouse model of spinal muscular atrophy46
TRIM25 activates Wnt/β-catenin signalling by destabilising MAT2A mRNA to drive thoracic aortic aneurysm development44
Alzheimer’s disease risk gene CD2AP is a dose-sensitive determinant of synaptic structure and plasticity44
Loss of TMCC2 activates endoplasm reticulum stress and causes auditory hair cell death43
The microRNA processorDROSHAis a candidate gene for a severe progressive neurological disorder42
Correction to: G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain41
Correction to: “Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using 38
Lysosomes and the pathogenesis of merosin-deficient congenital muscular dystrophy37
Expression of Concern: Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation36
Origins of tissue and cell-type specificity in mitochondrial DNA (mtDNA) disease36
Dissection of a Down syndrome-associated trisomy to separate the gene dosage-dependent and -independent effects of an extra chromosome34
Small molecule 1a reduces FMRpolyG-mediated toxicity in in vitro and in vivo models for FMR1 premutation34
Comprehensive phenotypic and functional analysis of dominant and recessiveFOXE3alleles in ocular developmental disorders34
Serum biomarkers are altered in UK Biobank participants with mosaic chromosomal alterations33
The novel potent GSK3 inhibitor AF3581 reverts fragile X syndrome phenotype29
Genetic and clinical determinants of abdominal aortic diameter: genome-wide association studies, exome array data and Mendelian randomization study29
AAV-mediated gene-replacement therapy restores viability of BCD patient iPSC derived RPE cells and vision of Cyp4v3 knockout mice29
Impaired cooperation between IFT74/BBS22–IFT81 and IFT25–IFT27/BBS19 causes Bardet-Biedl syndrome29
Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis29
Deep structure of DNA for genomic analysis28
Temporal dissection of Rai1 function reveals brain-derived neurotrophic factor as a potential therapeutic target for Smith–Magenis syndrome28
Non-canonical initiation factors modulate repeat-associated non-AUG translation28
NovelLRRK2mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors28
0.62626814842224